influenza c in alberta tarrant symposium 2012 kanti pabbaraju lab scientist provlab...

24
Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab [email protected]

Upload: hector-andrews

Post on 13-Jan-2016

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Influenza C in Alberta

TARRANT Symposium 2012Kanti Pabbaraju

Lab ScientistProvLab

[email protected]

Page 2: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Matsuzaki et al., JID, 2006 Tested 84946 patients from 1990 to 2004

170 (0.22%) were positive for FluC

Excluded all co-infections

Retrospective chart review

Studied symptoms and compared hospitalized

Vs non-hospitalized patients

Page 3: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Clinical features associated with influenza C virus infection.

Matsuzaki Y et al. J Infect Dis. 2006;193:1229-1235© 2006 by the Infectious Diseases Society of America

Page 4: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Clinical diagnoses in influenza C virus–infected children.

Matsuzaki Y et al. J Infect Dis. 2006;193:1229-1235© 2006 by the Infectious Diseases Society of America

Page 5: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Comparison of clinical features of type C and A influenza virus infections at Katsushima Pediatric Clinic during January–March 2002.

Matsuzaki Y et al. J Infect Dis. 2006;193:1229-1235© 2006 by the Infectious Diseases Society of America

Page 6: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Results

92% were less than 6 years old Fever, cough and rhinorrhea were the most

common symptoms 29 were hospitalized and 21 of these had LRT

such as pneumonia, bronchitis and brochiolitis Rate of hospitalization was significantly higher in

<2 year olds

Page 7: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

In addition A case of acute encephalopathy associated with influenza C has

been reported (Takayanagi, 2009).

Documented as the etiological cause of several outbreaks in

schools and the community (Ramos 2008, Matsuzaki 2007,

Matsuzaki 2002, GreenBaum 1998, Katagiri 1987, Katagiri 1983)

Thus overall burden of Influenza C infections should not be underestimated

Page 8: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Why is FluC under-diagnosed

Few reports describing its clinical features

Difficulty in isolating it (No suitable cell lines)

Amniotic inoculation of embryonated hen's eggs has been

employed to isolate the virus from clinical specimens.

Attributable to mild pathogenecity

Page 9: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Important epidemiological features Antigenically and genetically different strains co-circulate in a

community

Genetic re-assorting occurs frequently among strains

Newly emergent re-assortant viruses become predominant

Humans with antibodies to FluC can be repeatedly infected

Pigs and dogs have been reported to have antibodies

against Influenza C, thus it can cause zoonooses

Re-assortants with pig and human FluC genes reported

Page 10: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Design of RT-PCR assay Assay Design

Real-time PCR assay using labelled probes on the Taqman platform Target the conserved matrix gene

Strong pos Weak pos

Neg

Page 11: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Sensitivity, dynamic range, reproducibility, linearity Limit-of-detection was determined using quantified Influenza C RNA

prepared in-vitro

Copy number for in-vitro RNAAverage

Ct SD %CV

4.51E+08 11.52 0.08 0.68

4.51E+07 14.89 0.07 0.44

4.51E+06 18.24 0.05 0.25

4.51E+05 21.67 0.04 0.19

4.51E+04 25.07 0.07 0.28

4.51E+03 28.63 0.07 0.26

4.51E+02 31.91 0.10 0.32

4.51E+01 35.39 0.44 1.24

4.51E+00 39.18 0.89 2.28

Page 12: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Sensitivity, dynamic range, reproducibility, linearity

y = -3.4407x + 41.18

R2 = 0.9998

0

5

10

15

20

25

30

35

40

45

0.00E+00 1.00E+00 2.00E+00 3.00E+00 4.00E+00 5.00E+00 6.00E+00 7.00E+00 8.00E+00 9.00E+00 1.00E+01

R2 = 0.9998

Detection of a range of FluC viral loads - replicates

Good linearity over a large dynamic range

Page 13: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Specificity

different strains of influenza virus A and B, parainfluenza virus 1, 2, 3, 4A and 4B, RSV A and B, human coronaviruses 229E, NL63, HKU1 and OC43 human bocavirus, coxsackievirus A16 and B6, echovirus 2, human metapneumovirus, rhinovirus type 1B, adenovirus type 4, Legionella pneumophila, Mycoplasma pneumoniae, Bordetella bronchiseptica, B. holmseii, B. parapertussis, B. pertussis, Hemophilus influenzae, Neisseria meningitidis Streptococcus pneumoniae.

Test high copy number samples of common respiratory pathogens

Page 14: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Population screened

From Sept 1, 2010 to April 30, 2011

Children less than 10 years during hospital visits (n=427)

Respiratory outbreaks (n=47)

Randomly selected to include 55 samples per month

Multiple samples from the same patient were excluded

All specimens had tested negative for influenza A and B, RSV, human

metapneumovirus, parainfluenza types 1 to 4, coronavirus 229E, OC43, NL65 and

HKUI, adenovirus, entero/rhinovirus

Page 15: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Positive sample types Specimen type Total tested Total positive % positive in specimen type

Nasopharyngeal swab 313 7 2.24

Auger suction fluid 67 3 4.48

Nasopharyngeal fluid 45 1 2.22

Throat swab 24 0 0.00

Others 25 0 0.00

Nasopharyngeal swab Auger suction fluidNasopharyngeal fluid Throat swabOthers

n=24Positive=0n=45

Positive=1

n=67Positive=3

n=314Positive=7

n=25Positive=0

Page 16: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Age distribution

44

2 7 2 0

254

9383

2.15

2.41

2.76

0

50

100

150

200

250

300

<1 1 to 5 5 to 10 10 to 100

0.00

0.50

1.00

1.50

2.00

2.50

3.00# of Samples tested

# of Positives detected

% positve

Age in years

Per

cent

pos

itive

Num

ber

of s

ampl

es

Page 17: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Seasonality

1 13 4

2

3.77

1.561.79

5.66

6.25

0

10

20

30

40

50

60

70

80

Sep 10 Oct 10 Nov 10 Dec 10 Jan 11 Feb 11 Mar 11 Apr 11

0.00

1.00

2.00

3.00

4.00

5.00

6.00

7.00

Total tested

Total positives

%positive

Month-Year

Num

ber

of s

ampl

es

Per

cent

pos

itive

Page 18: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Monthly isolation of influenza C virus between December 1990 and November 2004.

Matsuzaki Y et al. J Infect Dis. 2006;193:1229-1235© 2006 by the Infectious Diseases Society of America

Page 19: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Phylogenetic tree for HE gene

Nucleotide Substitutions (x100)0

5.8

24

Aichi_81Kansas_79

Georgia_69Johannesburg_66

Aichi_99C11VC3502

SaoPaulo82Yamagata93

Paris_67Taylor_47

M11VC4753M11VC10161C11VC2921

Catalonia2009M11VC4941

Singapore_2006C11VC3087

Yamagata_2004Kanagawa_76

Fukuoka_2004Yamagata_98

Miyagi_92England_83

Pig_Beijing_81Yamagata_88

Yamagata_81NewJersey_76

Kyoto_79Sapporo_71

Greece_79Mississipi_80

C/Aichi/1/81

C/Yamagata/26/81

C/Taylor/1233/47 C/Sao Paulo/378/82

C/ Kanagawa/1/76

C/Mississippi/80

42 isolates (1947-1993)

revealed six lineages co-circulation was detected

>98% identity

93% identity

Page 20: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Co-circulation of different lineages

Leads to re-assortment and epidemics of the new strain

Page 21: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Phylogenetic tree for M gene

Nucleotide Substitutions (x100)0

2.6

2

Aichi_81Kansas_79

Johannesburg_66Mississippi_80

Greece_79Taylor_47

SaoYamagata_93

Kanagawa_76Kyoto_79NewJersey_76

Yamagata_81Yamagata_88

Pig_Beijing_81Aichi_99

England_83M11VC002193M11VC004941M11VC010161

C11VC002921C11VC004753M10VC021100

C11VC003087Miyagi_92

C11VC002616C11VC003502

C11VC004406

C/Yamagata/26/81-related

lineage

C/Aomori/74

C/Aichi/1/81- or C/Mississippi/80-

related lineage

>98% identity

Page 22: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Conclusions

Sensitive and specific for the detection of Influenza C

Good reproducibility

Is linear over a large dynamic range

Will facilitate for testing of influenza C viruses in

respiratory samples in a high throughput fashion

Page 23: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Future work screening of patient samples including children and

adults

Influenza C in outbreaks of unknown etiology

Studying the epidemiology Are FluC infections cyclical or endemic

Role of FluC in hemopoeitic dysfunctions

Better strain characterization of Influenza C isolates in

the community

Page 24: Influenza C in Alberta TARRANT Symposium 2012 Kanti Pabbaraju Lab Scientist ProvLab k.pabbaraju@provlab.ab.ca

Acknowledgements

Dr. Kevin Fonseca

Dr. Raymond Tellier

Sallene Wong

Anita Wong

Vinod Khurana and the MOD group